Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The stock traded as high as C$4.28 and last traded at C$4.04, with a volume of 23487 shares. The stock had previously closed at C$4.16.
Medexus Pharmaceuticals Price Performance
The firm has a market cap of C$135.66 million, a price-to-earnings ratio of -210.00 and a beta of 0.53. The business has a fifty day simple moving average of C$3.99 and a 200 day simple moving average of C$3.35.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
